The CheckMate 498 trial compared the efficacy of nivolumab with radiation therapy against TMZ and radiation therapy (Stupp regimen) in patients with newly diagnosed MGMT-unmethylated GBM [33]. This evidence concerns the gene MGMT and glioblastoma.